Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
fluorometholone + mecobalamin + thiamine
- Development stage
- Unknown
- Lead developer
- AbbVie
- Modality
- Small Molecules
- Administration
- Ophthalmic
01
Overview
A combination drug containing fluorometholone (an ophthalmic corticosteroid), mecobalamin (a form of vitamin B12), and thiamine (vitamin B1). This combination may be used for treating inflammatory eye conditions with concurrent vitamin supplementation to support nerve function.
- Other names
- flumetholon + mecobalamin + vitamin B1
02
Targets
MTR (Methionine synthase)GR (Glucocorticoid receptor)
Beyond the preview
Go deeper on fluorometholone + mecobalamin + thiamine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on fluorometholone + mecobalamin + thiamine.